Nirmeen N. Elmadany
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 08, 2023
Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.
Journal: Disease models & mechanisms
Published: September 01, 2022
Site-Specific Considerations on Engineered T Cells for Malignant Gliomas.
Journal: Biomedicines
Published: June 19, 2022
Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects.
Journal: Neurobiology of disease
Published: May 20, 2020
Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges.
Journal: Molecular pharmacology
Published: March 13, 2020
The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: June 21, 2019
Tenascin C regulates multiple microglial functions involving TLR4 signaling and HDAC1.
Journal: Brain, behavior, and immunity
Published: May 03, 2019
Influence of Genotype and Haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the Incidence of Breast Cancer--a Case-Control Study in Jordan.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026